Cardiac pacing in the long QT syndrome: Review of available data and practical recommendations

Journal of Cardiovascular Electrophysiology

Volumn 11, Issue 5, 2000, Pages 593-599

  Viskin, Sami ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Cardiac pacing; Long QT syndrome; Pacemakers; Torsades de pointes; Ventricular tachycardia

Indexed keywords

ADULT; ALGORITHM; BRADYCARDIA; CASE REPORT; CAUSE OF DEATH; DEFIBRILLATOR; FEMALE; GENOTYPE; HEART ARRHYTHMIA; HEART PACING; HEART RATE; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL; REPOLARIZATION; REVIEW; SCHOOL CHILD; TORSADE DES POINTES;

EID: 0034084919     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2000.tb00015.x     Document Type: Review

References (62)

1. 1. Eldar M, Griffin JC, Abbott JA, Benditt D, Bhandari A, Herre JM, Benson DW, Scheinman MM: Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol 1987; 10: 600-607.
2. 2. Moss AJ, Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL: Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation 1991;84:1524-1529.
3. 3. Eldar M, Griffin JC, Van Hare GF, Witherell C, Bhandari A, Benditt D, Scheinman MM: Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol 1992;20:830-837.
4. 4. Dorostkar PC, Eldar M, Belhassen B, Viskin S, Scheinman MM, Lee RJ: Long-term follow-up of patients with the idiopathic long QT syndrome treated with combined beta-blockers and chronic pacing. (Abstract) Circulation 1997;96(Suppl I):I-1172.
5. 5. Viskin S: The long QT syndromes and torsade de pointes. Lancet 1999;354:1625-1633.
6. 6. DiSegni E, Klein HO, David D, Libhaber C, Kaplinsky E: Overdrive pacing in quinidine syncope and other long QT-interval syndromes. Arch Intern Med 1980;140:1036-1040.
7. 7. Sclarovsky S, Strasberg B, Lewin R, Agmon J: Polymorphous ventricular tachycardia: Clinical features and treatment. Am J Cardiol 1979;44:339-345.
8. 8. Shimizu W, Antzelevitch C: Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997;96:2038-2047.
9. 9. Shimizu W, Antzelevitch C: Cellular basis for the ECG features of the LQT1 form of the long QT syndrome. Effects of beta-adrenergic agonists and antagonists and sodium channels blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998;98:2314-2322.
10. 10. Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantu F, Towbin JA, Keating MT, Hammoude H, Brown AM, Chen LS, et al: Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995;92:3381-3386.
11. 11. Swan H, Viitasalo M, Piipo K, Laitinen P, Kontula K, Toivonen L: Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 1999;34:823-829.
12. 12. Benhorin J, Medina A: Congenital long QT syndrome. N Engl J Med 1997;336:1568.
13. 13. Priori SG, Napolitano C, Cantu F, Schwartz PJ: Differential response to Na+ channel blockade, beta-adrenergic stimulation and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long QT syndrome. Experimental basis for gene-specific therapy. Circ Res 1996;78:1009-1015.
14. 14. Schwartz PJ, Moss AJ, Priori SG, Wang Q, Lehmann MH, Timothy K, Denjoy IF, Haverkamp W, Guicheney P, Paganini V, Scheinman MM, Karnes PS: Gene-specific influence on the triggers for cardiac arrest in the long QT syndrome. (Abstract) Circulation 1997;96(Suppl I):I-212.
15. 15. Priori SG, Barhanin J, Hauer RNW, Haverkamp W, Jongsma H, Kleber AG, McKenna WJ, Roden DM, Rudy Y, Schwartz K, Schwartz PJ, Towbin JA, Wilde AM: Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management. Parts I and II. Circulation 1999;99:518-528.
16. 16. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ: Influence of the genotype on the clinical course of the long QT syndrome. N Engl J Med 1998;339:960-965.
17. 17. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R: The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988; 31:115-172.
18. 18. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, Vincent GM: Multiple mechanisms in the long QT syndrome. Current knowledge, gaps, and future directions. Circulation 1996;94:1996-2012.
19. 19. Locati EH, Maison-Blanche P, Dejode P, Cauchemez B, Coumel P: Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings. J Am Coll Cardiol 1995;25:1564-1575.
20. 20. Viskin S, Alla SR, Barron HV, Heller K, Saxon L, Kitzis I, Van Hare GF, Wong MJ, Lesh MD, Scheinman MM: Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardiol 1996;28:1262-1268.
21. 21. Vos MA, Verduyn SC, Gorgels APM, Lipcsei G, Wellens HJJ: Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 1995;91:864-872.
22. 22. El-Sherif N, Caref EB, Chinushi M, Restivo M: Mechanism of arrhythmogenicity of the short-long cardiac sequence that precedes ventricular tachyarrhythmias in the long QT syndrome. J Am Coll Cardiol 1999;33:1415-1423.
23. 23. El-Sherif N, Chinushi M, Caref EB, Restivo M: Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long QT syndrome. Detailed analysis of ventricular tridimensional activation patterns. Circulation 1997;96:4392-4399.
24. 24. Kay GN, Plumb VJ, Arciniegas JG, Henthorn RW, Waldo AL: Torsade de pointes: The long-short initiating sequence and other clinical features: Observations in 32 patients. J Am Coll Cardiol 1983;2:806-817.
25. 25. Viskin S, Fish R, Zeltser D, Heller K, Brosh D, Laniado S, Barron HV: Arrhythmias in the congenital long QT syndrome: How often is torsade de pointes pause-dependent? Heart 2000; (In press).
26. 26. Brachmann J, Scherlag BJ, Rosenshtraukh LV, Lazzara R: Bradycardia-dependent triggered activity: Relevance to drug-induced multiform ventricular tachycardia. Circulation 1983;68:846-856.
27. 27. Wellens HJ, Vermeulen A, Durrer D: Ventricular fibrillation occurring on arousal from sleep by auditory stimuli. Circulation 1972;46:661-665.
28. 1). J Am Coll Cardiol 1999;33:327-332.
29. 29. Garza LA, Vick RL, Nora JJ, McNamara DG: Heritable Q-T prolongation without deafness. Circulation 1970;41:39-48.
30. 30. Tanel RE, Triedman JK, Walsh EP, Epstein MR, DeLucca JM, Mayer JE, Fishberger SB, Saul JP: High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome. J Cardiovasc Electrophysiol 1997;8:812-817.
31. 31. Van Hare GF, Franz MR, Roge C, Scheinman MM: Persistent functional atrioventricular block in two patients with prolonged QT intervals: Elucidation of the mechanism of block. PACE 1990;13: 608-618.
32. 32. Malfatto G, Rosen MR, Foresti A, Schwartz PJ: Idiopathic long QT syndrome exacerbated by beta-adrenergic blockade and responsive to left cardiac sympathetic denervation: Implications regarding electrophysiologic substrate and adrenergic modulation. J Cardiovasc Electrophysiol 1992;3:295-305.
33. 33. Kuo CS, Munakata K, Reddy CP, Surawicz B: Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential duration. Circulation 1983;67:1356-1367.
34. 34. Viskin S, Fish R, Zeltser D, Lesh M, Belhassen B, Dorostkar PC, Laniado S, Scheinman MM: Pause-dependent vs. non pause-dependent initiation of torsade de pointes in the congenital long QT syndrome. (Abstract) PACE 1998;21(Pt II):II-851.
35. 35. Rashba EJ, Zareba W, Moss AJ, Hall WJ, Robinson J, Locati EH, Schwartz PJ: Influence of pregnancy on the risk of cardiac events in patients with hereditary long QT syndrome. Circulation 1998; 97:451-456.
36. 36. Shinbane J, Wood M, Jensen N, Ellenbogen K, Fitzpatrick A, Scheinman M: Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. J Am Coll Cardiol 1997;29: 709-715.
37. 37. Schwartz PJ, Periti M, Malliani A: The long Q-T syndrome. Am Heart J 1975;89:378-390.
38. 38. Scott W, Dick M: Two:one atrioventricular block in infants with congenital long QT syndrome. Am J Cardiol 1987;60:1409-1410.
39. 39. Rosenbaum MB, Acunzo RS: Pseudo 2:1 atrioventricular block and T wave alternans in the long QT syndromes. (Editorial) J Am Coll Cardiol 1991;18:1363-1366.
40. 40. Schwartz PJ: The long QT syndrome. In Camm AJ, ed. Clinical Approaches to Tachyarrhythmias. Futura Publishing Co., Armonk, NY, 1998, pp. 1-104.
41. 41. Eggeling T, Hoeher M, Osterhues HH, Weismueller P, Hombach V: Significance of noninvasive diagnostic techniques in patients with long QT syndrome. Am J Cardiol 1992;70:1421-1426.
42. 42. Krahn AD, Klein GJ, Yee R: Hysteresis of the RT interval with exercise. A new marker for the long QT syndrome? Circulation 1997;96:1551-1556.
43. 43. Vincent GM, Jaiswal D, Timothy KW: Effects of exercise on heart rate. QT, QTc and QT/QS2 in the Romano-Ward inherited long QT syndrome. Am J Cardiol 1991;68:498-503.
44. 44. Antzelevitch C, Sicouri S: Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol 1994;23:259-277.
45. 45. Kuo CS, Amlie JP, Munakata K, Reddy CP, Surawicz B: Dispersion of monophasic action potential durations and activation times during atrial pacing, ventricular pacing, and ventricular premature stimulation in canine ventricles. Cardiovasc Res 1983;17:152-161.
46. 46. Thompson ME, Shaver JA: Undesirable cardiac arrhythmias associated with rate hysteresis pacemakers. Am J Cardiol 1976;38:685-688.
47. 47. Browne KF, Prystowsky E, Heger JJ, Chilson DA, Zipes D: Prolongation of the Q-T interval in man during sleep. Am J Cardiol 1983;52:55-59.
48. 48. Neyroud N, Maison-Blanche P, Denjoy I, Chevret S, Donger C, Dausse E, Fayn J, Badilini F, Menhabi N, Schwartz K, Guicheney P, Coumel P: Diagnostic performance of QT interval variables from 24-h electrocardiography in the long QT syndrome. Eur Heart J 1998;19:158-165.
49. 49. Goldman DS, Levine PA: Pacemaker-mediated polymorphic ventricular tachycardia. PACE 1998;21:1993-1995.
50. 50. Satoh T, Zipes DP: Rapid rates during bradycardia prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs. Circulation 1996;94:217-227.
51. 51. Krebs ME, Szwed JM, Shinn T, Miles WM, Zipes DP: Short-term rapid ventricular pacing prolongs ventricular refractoriness in patients. J Cardiovasc Electrophysiol 1998;9:1036-1042.
52. 52. Darpo B, Allared M, Edvardsson N: Torsades de pointes induced by transesophageal atrial stimulation after administration of almokalant. Int J Cardiol 1996;53:311-313.
53. 53. Verduyn SC, Vos MA, Zande J, Kulcsar A, Wellens HJJ: Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias. A comparison between almokalant and d-sotalol using the dog as its own control. J Am Coll Cardiol 1997;30:1575-1584.
54. 54. Klein HO, Levi A, Kaplinsky E, DiSegni E, David D: Congenital long QT syndrome: Deleterious effect of long-term high-rate ventricular pacing and definitive treatment by cardiac transplantation. Am Heart J 1996;132:1079-1081.
55. 55. Viskin S, Fish R, Roth A, Copperman Y: Prevention of torsade de pointes in the congenital long QT syndrome: Use of a pause-prevention pacing algorithm. Heart 1998;79:417-419.
56. 56. Viskin S, Fish R, Brosh D, Laniado S, Belhassen B, Copperman Y, Lesh MD, Scheinman MM, Saxon L: Prevention of pause-dependent torsade de pointes and malignant ventricular arrhythmias with a pause-preventing pacing algorithm. (Abstract) PACE 1998;21(Pt II):II-826.
57. 57. Lee JK, Yee R, Braney M, Stoop G, Begemann M, Dunne C, Klein GJ, Krahn AD, VanHemels NM: Acute testing of the rate-smoothed pacing algorithm for ventricular rate stabilization. PACE 1999;22:554-561.
58. 58. Benditt DG, Sutton R, Gammage M, Markowitz T, Gorski J, Nygaard G, Fetter J: "Rate-drop response" cardiac pacing for vasovagal syncope. Rate-Drop Response Investigators Group. J Interven Cardiac Electrophysiol 1999;3:27-33.
59. 59. Connolly SJ, Sheldon R, Roberts RS, Gent M, on Behalf of the Vasovagal Pacemaker Study Investigators: The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33:16-20.
60. 60. Burashnikov A, Antzelevitch C: Acceleration-induced action potential prolongation and early afterdepolarizations. J Cardiovasc Electrophysiol 1998;9:934-948.
61. 61. Sun ZH, Swan H, Viitasalo M, Toivonen L: Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome. J Am Coll Cardiol 1998;31:1400-1405.
62. 62. Hirao H, Shimizu W, Kurita T, Suyama K, Aihara N, Kamakura S, Shimomura K: Frequency-dependent electrophysiologic properties of ventricular repolarization in patients with congenital long QT syndrome. J Am Coll Cardiol 1996;28:1269-1277.